<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/47A19BC3-1395-402D-8C69-FB62D261798E"><gtr:id>47A19BC3-1395-402D-8C69-FB62D261798E</gtr:id><gtr:name>Federal University of Minas Gerais</gtr:name><gtr:address><gtr:line1>Av. Antonio Carlos, 6627, Pampulha</gtr:line1><gtr:line2>6627 - Pampulha</gtr:line2><gtr:postCode>31270-901</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Brazil</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8457F177-72B8-495C-B502-18A1EC2E4EFD"><gtr:id>8457F177-72B8-495C-B502-18A1EC2E4EFD</gtr:id><gtr:name>Flinders University</gtr:name><gtr:address><gtr:line1>Flinders University</gtr:line1><gtr:line2>Sturt Road, Bedford Park</gtr:line2><gtr:line3>GPO Box 2100</gtr:line3><gtr:line4>Adelaide</gtr:line4><gtr:postCode>5001</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/47A19BC3-1395-402D-8C69-FB62D261798E"><gtr:id>47A19BC3-1395-402D-8C69-FB62D261798E</gtr:id><gtr:name>Federal University of Minas Gerais</gtr:name><gtr:address><gtr:line1>Av. Antonio Carlos, 6627, Pampulha</gtr:line1><gtr:line2>6627 - Pampulha</gtr:line2><gtr:postCode>31270-901</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Brazil</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8457F177-72B8-495C-B502-18A1EC2E4EFD"><gtr:id>8457F177-72B8-495C-B502-18A1EC2E4EFD</gtr:id><gtr:name>Flinders University</gtr:name><gtr:address><gtr:line1>Flinders University</gtr:line1><gtr:line2>Sturt Road, Bedford Park</gtr:line2><gtr:line3>GPO Box 2100</gtr:line3><gtr:line4>Adelaide</gtr:line4><gtr:postCode>5001</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F066F897-B601-4188-B606-45CF7CD9E726"><gtr:id>F066F897-B601-4188-B606-45CF7CD9E726</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>WOOD</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_14103"><gtr:id>EF1482B8-33D4-485F-AC9B-CABB8A0BD44E</gtr:id><gtr:title>Accelerating discovery science to clinical translation: CiC3 - The Oxford MRC CiC Pipeline</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_14103</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The Confidence in Concept scheme is a key part of MRC?s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach ?? before seeking more substantive funding.&amp;nbsp; It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>650000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Flinders University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Assessment of a dengue vaccine efficacy in macaques at the University of Puerto Rico</gtr:description><gtr:id>E2516DE3-04BA-4700-8453-86E41216183A</gtr:id><gtr:impact>A grant awarded by InnovateUK for &amp;pound;488,611.</gtr:impact><gtr:outcomeId>57e9517d2248d1.20395093-1</gtr:outcomeId><gtr:partnerContribution>The University of Puerto Rico has a primate research centre and they have the expertise to challenge macaques with four dengue serotypes. This will contribute to the confirmation of vaccine efficacy against all dengue serotypes.</gtr:partnerContribution><gtr:piContribution>We have applied for a grant to InnovateUK, in order to assess efficacy of our dengue vaccine in macaques. We have been awarded a grant and this will be a major step towards a clinical trial in the future.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Federal University of Minas Gerais</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>Dengue Vaccine Efficacy in mice</gtr:description><gtr:id>470408E9-7F67-41AF-B4BE-F46A94D293FF</gtr:id><gtr:impact>We have established an agreement, supported by Oxford Research Services and the University of Minas Gerais. We have signed a contract document for the project.</gtr:impact><gtr:outcomeId>56db085839c014.13623097-1</gtr:outcomeId><gtr:partnerContribution>Prof. da Fonseca will provide his expertise and dengue strains to perform challenges in his lab in order to assess efficacy of the Oxford's vaccines. He will commit part of his time for the project, as well as the time of a postdoctoral scientist.</gtr:partnerContribution><gtr:piContribution>Our partner, Prof. Flavio Guimaraes da Fonseca has developed a mouse model to assess vaccine efficacy against dengue. In collaboration with Prof. da Fonseca, we will assess the efficacy of our dengue vaccines developed in Oxford, to determine the capacity to protect mice against a challenge with dengue viruses. To this end, we have developed various versions of dengue vaccines, which will be tested in Prof. da Fonseca's laboratory.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Oxford biotech deals highlight stature of UK university spinouts</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>41912FFB-07B7-4ADF-838E-45F0A10E7C3D</gtr:id><gtr:impact>http://www.evoxtherapeutics.com/news/2016/5/11/oxford-biotech-deals-highlight-stature-of-uk-university-spinouts</gtr:impact><gtr:outcomeId>58caa5efb6fdc2.82056710</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.evoxtherapeutics.com/news/2016/5/11/oxford-biotech-deals-highlight-stature-of-uk-university-spinouts</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar to OUHT Microbiology department</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>93AF194D-D54D-4E6F-A513-8B7B9D7D541B</gtr:id><gtr:impact>Gave an overview of research leading to my CRUK funded project, how this project would address significant knowledge gaps and what the Microbiology department would learn from our study.
Also suggested ideas for collaborations with members of the department.</gtr:impact><gtr:outcomeId>58c1a31d583417.14759196</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementia Friends - Public Engagement Event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>583CDD78-98E9-4F33-9AD1-389FC5505C7E</gtr:id><gtr:impact>This was a regional event organised by Dementia Friendly Chipping Norton, including a Dementia Friends Information Session, a couple of short research talks, and a panel Q&amp;amp;A. I contributed a talk and was a panel member.</gtr:impact><gtr:outcomeId>58ca5f8756fa46.40036842</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UKSF - Liverpool Research Training Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>185D5700-9B0D-473B-9645-30704EF86281</gtr:id><gtr:impact>The Stroke Research Training Day is aimed at&amp;nbsp;those who want to get&amp;nbsp;involved in&amp;nbsp;research for the first time as well as those who have already started in a&amp;nbsp;research career.

Around 85 delegates attended. 
The training day combined&amp;nbsp;presentations&amp;nbsp;and expert coaching by the Stroke Association Lecturers. This interactive day set out&amp;nbsp;a compelling case for stroke research, described&amp;nbsp;the main studies going on right now, and looked at&amp;nbsp;future horizons.&amp;nbsp;We explored&amp;nbsp;funding&amp;nbsp;opportunities, the role of the Research Design&amp;nbsp;Service and the critical role&amp;nbsp;that&amp;nbsp;people affected by stroke play in the research process.&amp;nbsp; 
Hands on coaching sessions included: how to create a poster and give a talk; how to balance clinical and research interests; how to respond to peer review comments;&amp;nbsp;choosing&amp;nbsp;the right&amp;nbsp;research methods.&amp;nbsp;&amp;nbsp;</gtr:impact><gtr:outcomeId>57f4fe98ddd1b7.78291430</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.stroke.org.uk/uksf-conference</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Biomanufacture of Nanofibre scaffolds for soft tissue repair</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D2806E6C-FEB0-4967-82A4-B123CEF9C201</gtr:id><gtr:outcomeId>56d44e8d550764.72050181</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EvOx</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>EvOx Therapeutics</gtr:fundingOrg><gtr:id>9A995B37-FD52-45E6-97EB-E8113A8DF8C0</gtr:id><gtr:outcomeId>58c95f3797b1c7.18569927</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100023</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Confidence in Concept (CiC) by MRC</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F87D26E4-E95B-483C-A97E-1AD8E588DE2C</gtr:id><gtr:outcomeId>5692b279b58275.90533798</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Action Duchenne translational research</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>Action Duchenne</gtr:fundingOrg><gtr:id>3DC85228-A4C1-47B9-BC44-2CB309EB04CB</gtr:id><gtr:outcomeId>58c96c5f4ac3c3.06469320</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>488611</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>New vaccines for global epidemics: development and manufacture</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>SBRI Healthcare</gtr:fundingOrg><gtr:fundingRef>TSB File Ref.: 972214. Application 	No. 71744-493192</gtr:fundingRef><gtr:id>C63969FC-1945-4BAB-9CA1-4EA86B997497</gtr:id><gtr:outcomeId>57e95237076949.14107855</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>287000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Immunology Project award</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>5CD1B585-98AA-4D7C-9B45-4F3DCB2B9CFD</gtr:id><gtr:outcomeId>56d9a9900d76e7.32182188</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Duchenne UK translational research</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>Duchenne UK</gtr:fundingOrg><gtr:id>6C68F6F8-7290-458D-BA19-B612C8F5013A</gtr:id><gtr:outcomeId>58c96c049bc3d4.63297101</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000000</gtr:amountPounds><gtr:country>Mexico, United Mexican States</gtr:country><gtr:currCode>MXN</gtr:currCode><gtr:currCountryCode>Mexico</gtr:currCountryCode><gtr:currLang>es_MX</gtr:currLang><gtr:description>'Frontiers of Science' A comparative study on diseases caused by the endemic and emerging viral agents Dengue, Chikungunya and Zika.</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>National Council on Science and Technology (CONACYT)</gtr:fundingOrg><gtr:fundingRef>Project No. 1192</gtr:fundingRef><gtr:id>535805E6-3FED-43C9-8D9A-3636F4763235</gtr:id><gtr:outcomeId>57e952e7682ed6.87627070</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We have developed a potential test for T cell lymphoma which may have future theraeutic relevance.</gtr:description><gtr:grantRef>MC_PC_14103</gtr:grantRef><gtr:id>A1C3A283-A0F8-4E6C-B0DA-63973BA0E701</gtr:id><gtr:impact>Academic work continues in order to validate the technology. Commercial interactions currently under negotiation.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>58c2e2f75d13c8.70883849</gtr:outcomeId><gtr:patentId>WO2016/051205A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Development of a test for T celllymphoma/leukaemia</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>We have developed a range of modulators to manage diseases associated with circadian rhythm disturbances. This could be of great utility in managing a multitude of orphan disorders associated with circadian rhythm disorders such as non-24 sleep wake disorder, advanced sleep phase syndrome and also other potential mainstream mood related disorders. Towards this we have identified a range of molecules and demonstrated their validity in a range of preclinical in vitro and in vivo models of the disease.</gtr:description><gtr:grantRef>MC_PC_14103</gtr:grantRef><gtr:id>B5B23457-5697-49AC-913E-11FD7A98CDD9</gtr:id><gtr:impact>This has resulted in establishing a new spin out &amp;quot;circadian therapeutics&amp;quot; and we are now seeking protection internationally.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>58c68a0d91e664.08889798</gtr:outcomeId><gtr:patentId>UK Patent Application No. 1606622.7</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Adenosine receptor modulators</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C20B5C8A-743F-47F8-910B-8F6C07EF55BB</gtr:id><gtr:title>A comparative evaluation of the effect of polymer chemistry and fiber orientation on mesenchymal stem cell differentiation.</gtr:title><gtr:parentPublicationTitle>Journal of biomedical materials research. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c60743f838135004672703b1d4d98f90"><gtr:id>c60743f838135004672703b1d4d98f90</gtr:id><gtr:otherNames>Rowland DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-3296</gtr:issn><gtr:outcomeId>58a56ac12cd8a0.28330555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02032693-A518-4C08-928E-102A7580996D</gtr:id><gtr:title>Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6fcc3df60bba17a8ae18a17fddae400"><gtr:id>b6fcc3df60bba17a8ae18a17fddae400</gtr:id><gtr:otherNames>Wartolowska K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>58a56ac2c45140.77435315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B30BB075-B0CC-4522-89E4-305EF454418D</gtr:id><gtr:title>H3K27ME3 DEMETHYLASES REGULATE IN VITRO CHONDROGENESIS AND CHONDROCYTE ACTIVITY IN OSTEOARTHRITIS</gtr:title><gtr:parentPublicationTitle>OSTEOARTHRITIS AND CARTILAGE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa12e2574f6921abed68e40be193fedf"><gtr:id>aa12e2574f6921abed68e40be193fedf</gtr:id><gtr:otherNames>Yapp C.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1063-4584</gtr:issn><gtr:outcomeId>58a56a2d1fc505.03355002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB178E41-AC7D-49D4-B007-4C13008E4272</gtr:id><gtr:title>Investigations on recyclisation and hydrolysis in avibactam mediated serine ?-lactamase inhibition.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09e36c120da7c68a327600769ab29add"><gtr:id>09e36c120da7c68a327600769ab29add</gtr:id><gtr:otherNames>Choi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>589ae04fd3b408.61986621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A273EA7A-94F8-4142-B43F-D4BD7C35BA9F</gtr:id><gtr:title>Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2107490ba1ae5f5dd21b0c1d4add91ca"><gtr:id>2107490ba1ae5f5dd21b0c1d4add91ca</gtr:id><gtr:otherNames>Calvopi?a K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>577d0e4bbcdb31.34600177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5838CBB2-B353-451E-AE20-B50096E299CB</gtr:id><gtr:title>Gene expression profiles of changes underlying different-sized human rotator cuff tendon tears.</gtr:title><gtr:parentPublicationTitle>Journal of shoulder and elbow surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3023d572a8081eb596eb42c770ace2a8"><gtr:id>3023d572a8081eb596eb42c770ace2a8</gtr:id><gtr:otherNames>Chaudhury S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-2746</gtr:issn><gtr:outcomeId>58a56ac0e6a967.34388446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7F79390-A3D2-4393-9D03-CC170A4CC58E</gtr:id><gtr:title>The Effects of Glucocorticoid on Tendon and Tendon Derived Cells.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0dc882ffe7b38eee946a1bf6d6612dd"><gtr:id>b0dc882ffe7b38eee946a1bf6d6612dd</gtr:id><gtr:otherNames>Dean BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>58a56ac1608373.05566205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>691F071C-944F-4B3F-AC7F-D29C8778CE9E</gtr:id><gtr:title>Past and projected temporal trends in arthroscopic hip surgery in England between 2002 and 2013.</gtr:title><gtr:parentPublicationTitle>BMJ open sport &amp; exercise medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5631dedc2427abc7e8fe281458752202"><gtr:id>5631dedc2427abc7e8fe281458752202</gtr:id><gtr:otherNames>Palmer AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2055-7647</gtr:issn><gtr:outcomeId>58a56ac33eeef9.13982443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89A4F3DD-CDC4-41C4-9B4F-4B24D3F712DC</gtr:id><gtr:title>Comparison of transforming growth factor beta expression in healthy and diseased human tendon.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/933365c646af9ac22798f511412e0b78"><gtr:id>933365c646af9ac22798f511412e0b78</gtr:id><gtr:otherNames>Goodier HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>58a56ac30a8902.04045475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13B5F2A7-35EA-4B79-8387-E30B9120E18C</gtr:id><gtr:title>Mechanical properties of all-suture anchors for rotator cuff repair.</gtr:title><gtr:parentPublicationTitle>Bone &amp; joint research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31bcf41d2b8ff1213cf2a19b68674b0d"><gtr:id>31bcf41d2b8ff1213cf2a19b68674b0d</gtr:id><gtr:otherNames>Nagra NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-3758</gtr:issn><gtr:outcomeId>58a56e3a1f79e2.43390288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>854CEAA6-C5BF-464F-8733-CF4B985C3A24</gtr:id><gtr:title>Effect of annealing on the mechanical properties and the degradation of electrospun polydioxanone filaments.</gtr:title><gtr:parentPublicationTitle>Journal of the mechanical behavior of biomedical materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efe5bda48f3143cceedfbf3a258d1c82"><gtr:id>efe5bda48f3143cceedfbf3a258d1c82</gtr:id><gtr:otherNames>Abhari RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1878-0180</gtr:issn><gtr:outcomeId>58c65dfab20252.72179896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05626E8B-DFC8-4434-A8E8-C9C39B90FA97</gtr:id><gtr:title>Insights into the Mechanistic Basis of Plasmid-Mediated Colistin Resistance from Crystal Structures of the Catalytic Domain of MCR-1.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/befc58d95b309466ced570b65ae0e450"><gtr:id>befc58d95b309466ced570b65ae0e450</gtr:id><gtr:otherNames>Hinchliffe P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>587f4525bef883.91282592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6945ED8E-C046-4214-A80E-3EFA095E4947</gtr:id><gtr:title>Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/688e1c764745aec0d9fd4c761052bef0"><gtr:id>688e1c764745aec0d9fd4c761052bef0</gtr:id><gtr:otherNames>Snelling SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a6f2d11307ce8.94978808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E997D292-2CDC-45E6-A2B8-3B6E8BC00D9F</gtr:id><gtr:title>The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4ba7152b364b7cf527e6722c90dd074"><gtr:id>d4ba7152b364b7cf527e6722c90dd074</gtr:id><gtr:otherNames>Wartolowska KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>58a56ac1c80eb6.09173604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9F19212-D8C8-4F51-8709-BD08317544D7</gtr:id><gtr:title>The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c03e8311a8ae457e437dec1acb830623"><gtr:id>c03e8311a8ae457e437dec1acb830623</gtr:id><gtr:otherNames>Bayliss LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58c65dfa2f01c6.31299000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C5093AA-7460-4063-AADD-C9F291C4F2B1</gtr:id><gtr:title>NMR-filtered virtual screening leads to non-metal chelating metallo-?-lactamase inhibitors.</gtr:title><gtr:parentPublicationTitle>Chemical science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07111f4196fe043435d46d8db76cbef8"><gtr:id>07111f4196fe043435d46d8db76cbef8</gtr:id><gtr:otherNames>Li GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-6520</gtr:issn><gtr:outcomeId>58999febb710b1.28288856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A98DFC5F-77E9-4464-A6F2-0078AE7A110E</gtr:id><gtr:title>Recent advances in understanding and preventing human papillomavirus-related disease.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ac969bceac9e6a459423c7c857bf129"><gtr:id>7ac969bceac9e6a459423c7c857bf129</gtr:id><gtr:otherNames>Hellner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>5aa025d567f084.27633867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE91CBEC-4B71-49A7-BA23-50889A76D555</gtr:id><gtr:title>Profibrotic mediators in tendon disease: a systematic review.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60f7a5c75d775c1dcf958e4502b67b91"><gtr:id>60f7a5c75d775c1dcf958e4502b67b91</gtr:id><gtr:otherNames>Morita W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>58a56ac21b6ed9.13337943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68FD4804-9C28-4BB7-AB8A-90A33C7C6A27</gtr:id><gtr:title>Resorbable electrospun polydioxanone fibres modify the behaviour of cells from both healthy and diseased human tendons.</gtr:title><gtr:parentPublicationTitle>European cells &amp; materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf869d458af610e2de2a90c6b0015a18"><gtr:id>bf869d458af610e2de2a90c6b0015a18</gtr:id><gtr:otherNames>Kendal A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-2262</gtr:issn><gtr:outcomeId>58c65df9df43f4.34922908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7FF54F6-71CE-4FE8-8C4A-F53396744DF2</gtr:id><gtr:title>H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6901191886018a99358f86d2f708defa"><gtr:id>6901191886018a99358f86d2f708defa</gtr:id><gtr:otherNames>Yapp C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>58a56ac24dc1f7.78918414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF997E31-B79B-449A-A32B-B3D57B6DFF2A</gtr:id><gtr:title>Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8a783e67f3fe9432f840ccd1d01778c"><gtr:id>b8a783e67f3fe9432f840ccd1d01778c</gtr:id><gtr:otherNames>Dakin SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a6f2d6c952db2.89797689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E08654D-1B8B-4AA4-8CB3-0A0F55EF69BE</gtr:id><gtr:title>Review: Emerging concepts in the pathogenesis of tendinopathy.</gtr:title><gtr:parentPublicationTitle>The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8137fa82536834e71c7a4d051a9f02de"><gtr:id>8137fa82536834e71c7a4d051a9f02de</gtr:id><gtr:otherNames>Dean BJF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1479-666X</gtr:issn><gtr:outcomeId>5a6f2d2e222cd2.48605595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>573E0A86-2F1D-4F56-A0D4-590AB5FBEDBF</gtr:id><gtr:title>A review of current surgical practice in the operative treatment of proximal humeral fractures: Does the PROFHER trial demonstrate a need for change?</gtr:title><gtr:parentPublicationTitle>Bone &amp; joint research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0dc882ffe7b38eee946a1bf6d6612dd"><gtr:id>b0dc882ffe7b38eee946a1bf6d6612dd</gtr:id><gtr:otherNames>Dean BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-3758</gtr:issn><gtr:outcomeId>58a56a2c9e61b0.02757674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D258743-D1C2-44D8-AA3F-98866F267E52</gtr:id><gtr:title>The role of national registries in improving patient safety for hip and knee replacements.</gtr:title><gtr:parentPublicationTitle>BMC musculoskeletal disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2169cf6cc0f970e1fc00efde96058a97"><gtr:id>2169cf6cc0f970e1fc00efde96058a97</gtr:id><gtr:otherNames>L?bbeke A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2474</gtr:issn><gtr:outcomeId>5a6f2dc5dd2387.69261797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38697E1D-BE3E-4E85-9C76-942D58C1200C</gtr:id><gtr:title>Translating Regenerative Biomaterials Into Clinical Practice.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5589413e17b3beb4e7da9e634d7124a1"><gtr:id>5589413e17b3beb4e7da9e634d7124a1</gtr:id><gtr:otherNames>Stace ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn><gtr:outcomeId>58a56ac1932e49.89401250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36E6BCF4-DCE0-4384-B457-CFE8CCE5C2E4</gtr:id><gtr:title>Interaction of Avibactam with Class B Metallo-?-Lactamases.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6de25d97265faf8f908a2a6c9c11892a"><gtr:id>6de25d97265faf8f908a2a6c9c11892a</gtr:id><gtr:otherNames>Abboud MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>581b5652530862.71165362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>980EAA8D-A3CC-4D43-BF80-ABBF87440F4B</gtr:id><gtr:title>A survey on beliefs and attitudes of trainee surgeons towards placebo.</gtr:title><gtr:parentPublicationTitle>BMC surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5443148f90d7d5f41f32f6fffbd8ef0"><gtr:id>b5443148f90d7d5f41f32f6fffbd8ef0</gtr:id><gtr:otherNames>Baldwin MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2482</gtr:issn><gtr:outcomeId>58a56ac28d59f3.61762525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4FF1085-EDCD-455E-B1BF-549CD9FC1482</gtr:id><gtr:title>Chronic inflammation is a feature of Achilles tendinopathy and rupture.</gtr:title><gtr:parentPublicationTitle>British journal of sports medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8a783e67f3fe9432f840ccd1d01778c"><gtr:id>b8a783e67f3fe9432f840ccd1d01778c</gtr:id><gtr:otherNames>Dakin SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0306-3674</gtr:issn><gtr:outcomeId>5a6f2d4ec86051.66990355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A59CC176-B4E1-4555-8252-05C249DC5EF7</gtr:id><gtr:title>Structural and Biochemical Characterization of Rm3, a Subclass B3 Metallo-?-Lactamase Identified from a Functional Metagenomic Study.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efa19b74bcd8e6ddb3c47b9529ff96ee"><gtr:id>efa19b74bcd8e6ddb3c47b9529ff96ee</gtr:id><gtr:otherNames>Salimraj R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>5899e9f3670582.88037651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54FB512C-41F0-4C9A-90F2-C5C3A4F1EC25</gtr:id><gtr:title>Investigating the use of curcumin-loaded electrospun filaments for soft tissue repair applications.</gtr:title><gtr:parentPublicationTitle>International journal of nanomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f789b71204866025002bedacd771f77"><gtr:id>5f789b71204866025002bedacd771f77</gtr:id><gtr:otherNames>Mouthuy PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1176-9114</gtr:issn><gtr:outcomeId>5a6f2d4eac45d9.40791430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F068E25-75D7-4072-9B34-08EECCE0A750</gtr:id><gtr:title>Evidence of insufficient quality of reporting in patent landscapes in the life sciences.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740b47608c2a17faae775070e5702f3"><gtr:id>5740b47608c2a17faae775070e5702f3</gtr:id><gtr:otherNames>Smith JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>58c65d7527c6c3.93926956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55D311CE-7AC1-4706-A9D6-6ABC2FA2C085</gtr:id><gtr:title>Dickkopf-3 is upregulated in osteoarthritis and has a chondroprotective role.</gtr:title><gtr:parentPublicationTitle>Osteoarthritis and cartilage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/688e1c764745aec0d9fd4c761052bef0"><gtr:id>688e1c764745aec0d9fd4c761052bef0</gtr:id><gtr:otherNames>Snelling SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1063-4584</gtr:issn><gtr:outcomeId>58a56a2cddd0b7.89690075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E72E62D-2FF3-41FA-99AE-45CA1D54CA18</gtr:id><gtr:title>Effectiveness of open and arthroscopic rotator cuff repair (UKUFF): a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The bone &amp; joint journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cba5f699b7a3ce461fdf862f3e576e71"><gtr:id>cba5f699b7a3ce461fdf862f3e576e71</gtr:id><gtr:otherNames>Carr A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2049-4394</gtr:issn><gtr:outcomeId>58c65dfa67f228.57435997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A1485D3-1B84-4494-B92D-B0F05EF65C7E</gtr:id><gtr:title>The road to avibactam: the first clinically useful non-?-lactam working somewhat like a ?-lactam.</gtr:title><gtr:parentPublicationTitle>Future medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3208f709bc1abed42116c259aef6b15"><gtr:id>e3208f709bc1abed42116c259aef6b15</gtr:id><gtr:otherNames>Wang DY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-8919</gtr:issn><gtr:outcomeId>5899e9f3366b75.00842244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD81F2B6-7E71-4C09-9A9E-82D070A9F7AB</gtr:id><gtr:title>Persistent stromal fibroblast activation is present in chronic tendinopathy.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8a783e67f3fe9432f840ccd1d01778c"><gtr:id>b8a783e67f3fe9432f840ccd1d01778c</gtr:id><gtr:otherNames>Dakin SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>58a56e3a711849.68557238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>263804DF-4C72-42CE-8E9F-2B45086B4417</gtr:id><gtr:title>Therapeutic HPV vaccines.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical obstetrics &amp; gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/215a458258dd460674f9cc98e1c2b628"><gtr:id>215a458258dd460674f9cc98e1c2b628</gtr:id><gtr:otherNames>Hancock G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1521-6934</gtr:issn><gtr:outcomeId>5aa025d5b7ad38.10746421</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_14103</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>